Symposium: Cannabis Policy: Misaligned With Science?-Symposium: Cannabis Policy: Misaligned With Science?

Video Transcription

Video Summary

In this video transcript, Dr. Kevin Hill discusses the need to integrate cannabis use into regular screenings with patients and the importance of motivational interviewing when discussing cannabis. He highlights the increase in cannabis use disorder rates and the potential risks associated with cannabis use. Dr. Hill also mentions screening and assessment tools for cannabis use disorder and the importance of treating co-occurring substance use disorders and psychiatric conditions. He suggests using anti-craving medications and managing withdrawal symptoms in the absence of FDA-approved medications for cannabis use disorder. Dr. Hill provides resources on cannabis policy and emphasizes the need for further research and advocacy.<br /><br />Dr. Smeeeta Das discusses changes in cannabis markets and their impact on public health. She highlights the increase in cannabis potency and the proliferation of different cannabis products. Dr. Das discusses the impact of these changes on arrest rates, cannabis hyperemesis syndrome, and poisonings among children. She addresses concerns about the commercialization of cannabis markets and the effects of low-cost, high-potency products on use patterns. Dr. Das emphasizes the need for clinicians and policymakers to be attentive to these changes and advocate for appropriate regulations and safeguards.<br /><br />Overall, the panelists provide insights into cannabis policy, its impact on public health, and the importance of evidence-based approaches to addressing cannabis use disorder. The video discusses the discrepancy between current laws and scientific evidence, highlighting the need for more research and informed consent when discussing cannabis use with patients. No credits were mentioned in the transcript.

Keywords

cannabis use

regular screenings

motivational interviewing

cannabis use disorder

potential risks

screening tools

assessment tools

co-occurring substance use disorders

psychiatric conditions

anti-craving medications

withdrawal symptoms

cannabis policy

further research

advocacy

cannabis markets

	The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.		400 Massasoit Avenue Suite 108 East Providence, RI 02914 cmecpd@aaap.org Privacy	About Advocacy Membership Fellowship Education and Resources Training Events